Actinium Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$90
$0
$0
$810
Gross Profit
-116
-204
-205
-204
EBITDA
-4,925
-6,674
-15,733
-6,448
EBIT
-5,131
-6,878
-15,938
-6,652
Net Income
-5,131
-6,878
-15,938
-6,652
Net Change In Cash
90
0
0
810
Free Cash Flow
-6,325
-5,392
-7,574
-5,751
Cash
53,391
59,928
65,325
72,904
Basic Shares
31,195
31,195
31,196
31,196

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$0
$81
$1,030
$1,144
Gross Profit
-811
81
1,030
620
EBITDA
-37,432
-51,130
-33,405
-24,250
EBIT
-38,243
-51,920
-34,104
-24,774
Net Income
-38,243
-48,818
-33,017
-24,774
Net Change In Cash
0
81
1,030
1,144
Cost of Revenue
14,222
Free Cash Flow
-33,083
-47,488
8,278
-20,999
Cash
72,904
76,677
108,910
77,829
Basic Shares
30,070
26,604
24,142
20,568

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.16
2025-06-30
-$0.22
2025-03-31
-$0.51